HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra De Jonghe Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2015Successful integration of nonclinical and clinical findings in interpreting the clinical relevance of rodent neoplasia with a new chemical entity.
9/2014Carbohydrate malabsorption mechanism for tumor formation in rats treated with the SGLT2 inhibitor canagliflozin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandra De Jonghe Research Topics

Disease

3Hyperplasia
01/2023 - 12/2014
3Neoplasms (Cancer)
11/2017 - 09/2014
3Infections
01/2016 - 01/2015
2Pheochromocytoma
11/2017 - 12/2014
2Injection Site Reaction
02/2016 - 01/2016
2Inflammation (Inflammations)
02/2016 - 05/2015
2Persistent Infection
01/2016 - 05/2015
2Type 2 Diabetes Mellitus (MODY)
01/2015 - 09/2014
2Hyperostosis
12/2014 - 09/2014
1Thrombocytopenia (Thrombopenia)
11/2023
1Thrombosis (Thrombus)
11/2023
1Methemoglobinemia
01/2023
1Hypertrophy
01/2023
1Chronic Hepatitis B
12/2021
1Chemical and Drug Induced Liver Injury
01/2021
1Brain Stem Neoplasms (Brain Stem Tumor)
11/2017
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2017
1Hepatitis
01/2016
1Necrosis
12/2015
1Cardiomyopathies (Cardiomyopathy)
02/2008
1Vitamin K Deficiency
02/2008

Drug/Important Bio-Agent (IBA)

4CanagliflozinIBA
11/2017 - 09/2014
4Glucose (Dextrose)FDA LinkGeneric
11/2017 - 09/2014
3Sodium-Glucose Transporter 2 InhibitorsIBA
11/2017 - 09/2014
2CarbohydratesIBA
11/2017 - 09/2014
2ChemokinesIBA
02/2016 - 05/2015
2CytokinesIBA
01/2016 - 05/2015
2CalciumIBA
12/2014 - 09/2014
1Ad26COVS1IBA
11/2023
1VaccinesIBA
11/2023
1SARS-CoV-2 spike proteinIBA
11/2023
1Thyroid HormonesIBA
01/2023
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2023
1Toll-Like Receptor 7IBA
12/2021
1atabecestatIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1bedaquiline (R207910)IBA
01/2017
1SuspensionsIBA
02/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2016
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2016
1InterferonsIBA
01/2016
1ProdrugsIBA
01/2016
1LipidsIBA
12/2015
1Antiviral Agents (Antivirals)IBA
05/2015
1LigandsIBA
05/2015
1Toll-Like Receptor 4IBA
05/2015
1LipopolysaccharidesIBA
05/2015
1SymportersIBA
01/2015
12- (6- ((2- (3- hydroxypropyl)- 5- methylphenylamino)methyl)- 2- (3- morpholin- 4- ylpropylamino)benzoimidazol- 1- ylmethyl)- 6- methylpyridin- 3- olIBA
01/2015
1SodiumIBA
01/2015
1Calcium-Regulating Hormones and AgentsIBA
12/2014
1Parathyroid Hormone (Parathormone)IBA
12/2014
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
12/2014
1Vitamin KFDA Link
02/2008
1Reverse Transcriptase InhibitorsIBA
02/2008
1NucleosidesIBA
02/2008

Therapy/Procedure

1Intravenous Administration
11/2023
1Injections
01/2016